Podcast
Questions and Answers
What is the rate-limiting step in catecholamine biosynthesis?
What is the rate-limiting step in catecholamine biosynthesis?
- Crossing of the blood-brain barrier by catecholamines
- Ring hydroxylation of L-tyrosine to L-dopa (correct)
- Conversion of L-dopa to dopamine
- Formation of pyridoxal phosphate
Which enzyme catalyzes the conversion of L-tyrosine to L-dopa?
Which enzyme catalyzes the conversion of L-tyrosine to L-dopa?
- Phenylethanolamine N-methyltransferase
- Dopamine beta-hydroxylase
- Tyrosine hydroxylase (correct)
- Dopa decarboxylase
Which compound can cross the blood-brain barrier and is used for treatment in diseases like Parkinson's?
Which compound can cross the blood-brain barrier and is used for treatment in diseases like Parkinson's?
- L-dopa (correct)
- Tetrahydropteridine
- L-tyrosine
- Dopamine
In the presence of which cofactor does dopa decarboxylase catalyze the conversion of L-dopa to dopamine?
In the presence of which cofactor does dopa decarboxylase catalyze the conversion of L-dopa to dopamine?
What role does a-methyldopa play in the catecholamine biosynthesis pathway?
What role does a-methyldopa play in the catecholamine biosynthesis pathway?
What is the end product of the ring hydroxylation step in catecholamine biosynthesis?
What is the end product of the ring hydroxylation step in catecholamine biosynthesis?
Flashcards are hidden until you start studying
Study Notes
Catecholamine Biosynthesis
- Occurs in the cytoplasm of chromaffin cells
Ring Hydroxylation
- Converts L-tyrosine to L-dopa
- Catalyzed by tyrosine hydroxylase in the presence of tetrahydropteridine
- Irreversible reaction
- Rate-limiting step of catecholamine biosynthesis
- Catecholamines cannot cross the blood-brain barrier, must be synthesized locally
- L-dopa can cross the blood-brain barrier, used to treat CNS diseases like Parkinson's disease
Decarboxylation
- Converts L-dopa to dopamine
- Catalyzed by dopa decarboxylase in the presence of pyridoxal phosphate
- Irreversible reaction
- Compounds like a-methyldopa act as competitive inhibitors, treating hypertension caused by high catecholamine levels
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.